Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate - an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction

By Zelefsky M.J.   Mckee A.B.   Lee H.   Leibel S.A.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 775-778

Elsevier

Access to resources Recommend Favorite

A double-blind, placebo-controlled, efficacy and safety study of topical gel formulation of 1% alprostadil (Topiglan) for the in-office treatment of erectile dysfunction

By Goldstein I.   Payton T.R.   Schechter P.J.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 301-305

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study

By Caruso S.   Intelisano G.   Farina M.   DiMari L.   Agnello C.   Giammusso B.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 922-927

Elsevier

Access to resources Recommend Favorite

Treatment of erectile dysfunction with sildenafil citrate (Viagra) after radiation therapy for prostate cancer

By Kedia S.   Zippe C.D.   Agarwal A.   Nelson D.R.   Lakin M.M.  

Urology, Vol. 54, Iss. 2, 1999-08 ,pp. : 308-312

Elsevier

Access to resources Recommend Favorite

An open-label study of abarelix in men with symptomatic prostate cancer at risk of treatment with LHRH agonists

By Koch M.   Steidle C.   Brosman S.   Centeno A.   Gaylis F.   Campion M.   Garnick M.B.   ABARELIX STUDY GROUP  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 877-882

Elsevier

Access to resources Recommend Favorite